Andrew Schiff

Aisling Capital Managing Partner

Photo of Andrew Schiff, Managing Partner at Aisling Capital
CompanyDeal TypeAmountDate
Agile TherapeuticsPost-IPO Equity$20MFeb 2015
Miramar LabsSeries D$26MOct 2014
Agile TherapeuticsSeries C$40M (Lead)Jul 2012
Zeltiq AestheticsSeries D$25M (Lead)Jun 2010
TransEnterixPost-IPO Equity$55M (Lead)Oct 2009
Sirion TherapeuticsSeries B$45M (Lead)Apr 2007
SkinMedicaSeries D$30M (Lead)Jul 2004
No media found for Andrew Schiff.
cb
Photo of Aftab Kherani, Partner at Aisling Capital

Aisling Capital

Photo of Ayman Sabi, Partner at Aisling Capital

Aisling Capital

Photo of Dennis Purcell, Aisling Capital

Aisling Capital

Photo of Dov Goldstein, Managing Partner at Aisling Capital

Aisling Capital

Photo of Eric Aguiar, Partner at Aisling Capital

Aisling Capital